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Edited by Francesc PosasAbstract Cytoplasmic volume undergoes a series of changes
during mitosis in eukaryotes; in turn, signaling events such as os-
motic stress can regulate the cytoplasmic volume in cells. In
some organisms, increase in cytoplasmic-to-nuclear volume ratio
was seen to aﬀect the growth potential in cells, however, the
mechanistics of such a regulation, if at all present, was unclear.
In a computational model, we have constructed a growth factor-
induced signaling pathway leading to AP-1 heterodimer forma-
tion through transcriptional regulation, and analyzed the eﬀects
of increasing the cytoplasmic-to-nuclear ratio on c-jun transcrip-
tion and AP-1 complex. We have observed that larger cytoplas-
mic volumes caused both an increase in the ﬁnal AP-1 product
and a delay in the time of AP-1 accumulation.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Changes in the cytoplasmic volume can occur due to a num-
ber of diﬀerent reasons, such as volume overload in cardiac
hypertrophy, osmotic stress or other signals, and aﬀect a vari-
ety of cellular responses, including metabolism and gene regu-
lation [1,2]. Growth rate in some cells was shown to correlate
well with changes in the cell volume; for example, the cytoplas-
mic water content in Corynebacterium was found to be depen-
dent on both growth phase and the extent of osmotic stress,
with maximal cytoplasmic values being highest at the maximal
growth rate, while no active volume regulation was observed in
stationary cells [2]. In addition, in NIH3T3 ﬁbroblasts the exo-
genic expression of an oncogenic form of Ras, which increase
proliferative capacity of these cells, also appears to shift cell
volume regulation by activating Na+/H+ exchange and Na+,
K+, Cl cotransport, thought to be governed by changes in
the cytoskeleton [3].
Cell division requires an increase in surface area to volume
ratio, and in the early stages of sea urchin embryonic develop-*Corresponding author. Fax: +90 216 578 04 00.
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doi:10.1016/j.febslet.2004.11.104ment (prior to the 8-cell stage) a brief decrease in cytoplasmic
volume is observed, followed by an increase in the surface area
and cell volume [4]. The egg volume of a tropical sea urchin,
Echinometra mathaei, was found to be about half of eggs from
some other species, with embryonic cleavage time about one
cell cycle earlier than others, and early developmental events
were found to depend more on the nucleo-cytoplasmic ratio
rather than the cleavage cycle [5].
Cellular swelling has emerged as an important initiator of
metabolic and proliferative changes in various cells [6]. In
swelling of liver cells upon regenerative stimuli, a relation-
ship between cell volume increase and proliferative activity
has been observed [6]. Through mechanotransduction, cell
volume is an important regulator of signaling and transcrip-
tional cascades, including MAPKs, PKC, NF-jB, and AP-1
[6].
AP-1 complex is composed of transcription factors c-Fos
and c-Jun, and is responsive to phorbol ester stimulation
[7–9]. Moreover, constitutive activation of AP-1 complex,
resulting from unregulated expression of either c-fos or c-jun
protooncogenes, is suﬃcient to drive abnormal cell prolifera-
tion, leading to cell transformation [7,8].
Activation of the MAPK pathway by growth factors leads
to immediate-early gene (IEG) regulation, most notably
expression of the c-fos protooncogene by ternary complex
factor (TCF) Elk-1 and the serum response factor (SRF)
(Fig. 1). Upon phosphorylation and assembly of the ternary
complex on the serum response element (SRE), RNA poly-
merase II is recruited to the promoter and transcription
from the c-fos promoter ensues (Fig. 1(a)). c-fos mRNA
translocates to the cytoplasm and is translated into c-Fos
transcription factor, which heterodimerizes with c-Jun pro-
tein to form the AP-1 complex. AP-1 heterodimer, among
other targets such as c-myb, cyclin D3, and DNA polymerase
a that regulate the cell cycle, also regulates the expression of
c-jun, ensuring positive feedback regulation on this promoter
[10–13].
In this study, the transcriptional and translational events
leading to AP-1 complex formation in the ﬁrst 60 min of
growth factor stimulation in relation to diﬀerent cytoplas-
mic-to-nuclear volume ratios are computationally analyzed
using the GEPASI 3.30 biochemical simulation software pack-
age. Our results show that increasing the cytoplasmic volume
threefold is suﬃcient to increase the amount of AP-1 complex,
without aﬀecting the rate of c-fos transcription or the amount
of cytoplasmic c-Jun protein. However, in spite of the increaseblished by Elsevier B.V. All rights reserved.
Fig. 1. A schematic of the reaction steps of the pathway modeled in this study. The major steps upon growth factor (Ligand, L) binding to the
receptor (R) to activation of downstream MAPK signaling cascade, and transcriptional regulation loops. See Section 2 for details.
434 I. Oney et al. / FEBS Letters 579 (2005) 433–440in levels, the time of AP-1 complex formation is signiﬁcantly
delayed.2. Materials and methods
2.1. Model description
This model is composed of two main compartments: the cyto-
plasm and the nucleus. In the ﬁrst compartment, binding of growth
factor (epidermal growth factor, EGF, also denoted as L) to the cell
surface receptor (Rs) yields a receptor–ligand complex (RL) (Fig. 1).
The receptor–ligand concentrations were based on previously re-
ported values for EGF and EGF receptors in epithelial cells
[15,16]. The cells are calculated to have maximal response over a
broad range of EGF concentrations; we routinely used EGF at
100 nM in parallel with experimental conditions. EGF is provided
to the in silico system in a continuous manner. The number of
receptor molecules, number of adaptors, aﬃnity kinetics, autoregula-
tory loops and many other parameters aﬀect the transient vs. sus-
tained nature of mitogenic response in cells. Comparison of EGF
and NGF stimuli, for example, has shown that even upon continu-
ous administration of EGF the cells show transient activation, un-
less receptors are overexpressed or an autoregulatory loop is
modiﬁed [17,18].
The RL complexes associate to produce the R2L2 dimers. Only the
active R2L2 species is internalized via a ligand-induced pathway,
through binding to cell surface coated pit adaptor proteins (CPP)
[17,18]. Total active receptor was deﬁned as the sum of receptor–ligand
dimers (R2L2), internalized receptor–ligand dimers (R2L2i), and inter-
nal receptor dimers after ligand degradation (R2i). The intracellularevents that take place after receptor stimulation have been broken
down to discrete steps. Activated receptors bind the growth factor
receptor binding protein 2 (Grb2), which then complexes with SOS,
recruiting Ras-GTP to the vicinity.
Ras-GTP activates Raf, the ﬁrst kinase of the pathway, or the
MAPK kinase kinase (MAPKKK/MEKK) (Fig. 1). Activated Raf
triggers the activation of the MAPK kinase MEK, which phosphor-
ylates and activates MAPK/ERK [18]. Downregulation of the
MAPK cascade occurs through dephosphorylation of the cascade
elements, inexplicitly included in the model as reverse steps of
reactions.
The doubly phosphorylated ERK, ERKPP, was taken to be the ac-
tive enzyme that can phosphorylate the ETS domain factor, Elk-1,
based on experimentally determined kinetic values [19]. The active
ETS-domain factor Elk-1 (Elk-1-P) and SRF (SRF-P) complex can re-
cruit the transcription machinery (SEPpol), initiating transcription
(Fig. 1). The association kinetics has been based on the experimental
values obtained using Ets-1 transcription factor [20]. Obviously, not
all transcription factors will have the same association–dissociation
kinetics with each other, however in the absence of experimentally
determined values the model was based on the closest approximation.
Downregulation of both Elk-1-P and SRF-P occurs through their
dephosphorylation, upon which they dissociate from the actively tran-
scribing complex, eﬀectively resulting in the recycling of the transcrip-
tion factors.
Nucleotide triphosphates (NTPs) have been assumed to be in mo-
lar excess of all other metabolites in this model. The kinetic param-
eters for transcription were taken from experiments with RNA
polymerase II and interleukin promoter [21]. The active RNApol
II-containing complexes are assumed to carry out c-fos and c-jun
transcription reactions with similar kinetics, since both genes are
rapidly turned on in response to mitogens.
I. Oney et al. / FEBS Letters 579 (2005) 433–440 435Once transcribed, these messenger RNAs then associate with the
translational machinery, the ribosomes, and are translated into the
respective proteins. The kinetic parameters for the translation reac-
tions were based on dipeptide synthesis kinetics [22]. As with the
NTPs, the amino acids (AAs) have also been assumed to be in molar
excess of all other metabolites for the purposes of this model (i.e.,
the individual nucleotide and amino acid metabolism pathways have
been excluded from this study).
Among the many targets of AP-1 complex are the cell cycle genes
such as c-myc, hence AP-1 formation is assumed to be indicative of cell
cycle potential in this model. One of the target promoters of the AP-1
heterodimer is the c-jun promoter, thereby providing autoregulatory
feedback (Fig. 1).
2.2. Simulation of the model
To simulate replication potential of cell, biochemical simulation
software package GEPASI 3.30 has been used. The pathway has been
modeled in terms of reaction steps for which both rate equation and
rate constants are speciﬁed. The software package utilizes these data
to calculate the change in concentrations of species that produced dur-
ing signaling pathway [23–25].
The reaction steps of the model, the kinetic type for each reaction
step, and the reference for the appropriate kinetic parameter values
are summarized in Table 1. The parameters have been based on exper-
imentally determined values wherever available. When diﬀerent
parameters were reported in diﬀerent assay systems, the average of
these values has been used. There are two deﬁned compartments in this
model, namely cytoplasm and nucleus, and the volumes of these two
compartments have been altered to simulate various nucleocytoplas-
mic volume ratios, and representative results with cytoplasmic-to-nu-
clear ratios of 1, 2, 3, and 4 are presented. Nuclear volume (Vn) was
always kept constant, while cytoplasmic volume (Vc) was varied. The
volumes were initially based on values found in experimental reports
[26] (see Table 2).
When dealing with a multi-compartment model in Gepasi, it
should be noted that for metabolites passing from one compartment
to the other, the decrease of metabolite concentration in one com-
partment is not equal to the increase in its concentration in the
other compartment, due to diﬀerences in the volume of these diﬀer-
ent compartments [23–25]. Therefore, the changes in metabolites and
reaction products are reported in this manuscript as molecules
rather than concentrations. In addition, since the kinetic constants
are usually deﬁned in terms of concentrations per unit time, the pro-
gram will not know which compartment to be used as reference for
the ﬂuxes, therefore these kinetic values have to be estimated by the
user in units of amounts per time. These re-estimated values include
nuclear translocation and nuclear exit rates. The volumes of cyto-
plasm and nucleus compartments are speciﬁed in the program as
separate entities, and the program performs necessary conversions
using these values.
The simulation data were analyzed and graphs were generated using
MS Excel package and SigmaPlot application software. The y-axis of
graphs represents changes in RNA or protein amounts (in molecules)
so as to avoid confusions due to volume changes.3. Results and discussion
MAPK activation was carried out for 60 min of continu-
ous exposure to 100 nM Epidermal Growth Factor (EGF).
The eﬀect of cytoplasmic-to-nuclear volume ratio on the
replication potential was monitored by AP-1 complex forma-
tion. Result of simulation are plotted molecule per compart-
ment versus time at diﬀerent Vc/Vn values (Vc/Vn = 1, 2, 3,
and 4). Biologically relevant Vc/Vn for mammalian cells is
between 2 and 3, depending on the cell type [27,28].
Under the conditions used in this model, 100 nM EGF stim-
ulation causes transient activation of the EGF pathway [18].
Increasing the cytoplasmic volume two- and threefold in-
creases maximal c-fos mRNA amount from 1.01 · 103 to
1.46 · 103 and to 1.94 · 103 molecules per nucleus, respectively(Fig. 2(a)). The initial rate of transcription appears unaﬀected
by changes in cytoplasmic volume (Fig. 2(a)). Interestingly,
however, the time of nuclear exit of c-fos mRNA appears to
be delayed when cytoplasmic volume is increased, resulting
in accumulation of nuclear c-fos mRNA (Fig. 2(a), 15, 20,
and 27 min in Vc/Vn ratios of 1, 2, and 3, respectively). This
is most probably due to the fact that SEPpol complex, once ac-
tive, keeps transcribing more c-fos RNA, and as the cytoplas-
mic volume is changed, the breakdown of the active complex
takes longer, resulting in a drop of c-fos RNA levels that is
perceived as delayed nuclear exit. The delay is reﬂected in
the cytoplasmic c-fos protein levels (Fig. 2(b)). While there ap-
pears to be no signiﬁcant change in the cytoplasmic c-fos levels
(1.43 · 104, 1.47 · 104, and 1.59 · 104 molecules/cytoplasm
with Vc/Vn of 1, 2, and 3, respectively; Fig. 2(b)), the time of
accumulation varies with varying cytoplasmic volumes. How-
ever, the rate of accumulation, the maximal c-fos protein lev-
els, and the time these maximal levels are achieved are all
aﬀected by cytoplasmic volume in nuclear c-fos protein (Fig.
2(c)), with levels dropping soon after reaching their maximal
amount, possibly due to sequestering of the c-fos protein in
the AP-1 complex. Maximal nuclear c-fos protein amount in-
creased from 4.37 · 104 to 6.41 · 104, and 9.45 · 104 molecules
when Vc/Vn ratio is changed to 1, 2, and 3, respectively (Fig.
2(c)). The kinetic proﬁle remains similar for Vc/Vn ratio of 4
(Fig. 2).
It is known that proteosome degradation of c-fos, for
example, is required for normal cell proliferation, and stabi-
lizing mutations in viral v-fos proteins lead to transforma-
tion of cells [29–31]. Since we do not simulate the 24-h
cycle of the cell, in this study we are not concerned with
a possibility of transformation, but we are merely asking
whether the volume change has any eﬀect whatsoever on
the AP-1 complex as one of the key regulators of cell cycle.
It should also be noted, however, that the half-life of c-Fos
in cycling cells is 54 min [29], by which time the AP-1 com-
plex is long accumulated at its steady-state levels. Since this
model does not involve events downstream of AP-1, the
downregulation of the AP-1 complex does not seem to be
a priority for the purposes of this model.
Changes in Vc/Vn ratio do not seem to aﬀect maximal levels
of nuclear c-jun mRNA concentration but rather the time of
accumulation (Fig. 3(a)). By increasing Vc/Vn ratio, the time
of c-jun mRNA transcription in the nucleus is delayed from
15 to 21, 27, and 29 min as Vc/Vn increased from 1 to 2, 3,
and 4, respectively (Fig. 3(a)). This result implies that
although changes in cytoplasmic volume may aﬀect the
amount of transcription products, the reaction soon reaches
steady-state levels, possibly due to both the autoregulatory
feedback loop ensuring constant transcription until the mech-
anism is shut oﬀ and the rapid export of the c-jun transcript
(see below). The time delay in transcriptional initiation from
the c-jun promoter is reﬂected in the accumulation of cyto-
plasmic c-jun protein, while there is very little, if any, increase
in the maximal levels of cytoplasmic c-jun (2.89 · 105,
3.12 · 105, and 3.51 · 105 molecules per cytoplasm with
Vc/Vn of 1, 2, and 3, respectively; Fig. 3(b)). However, the
levels suddenly jump to around twofold when the ratio is
increased to 4 (Fig. 3(b)), after a ratio of 5 and above we
considered the results of the program unreliable because of
non-physiological levels (data not shown). It would appear
that at the physiological ratios of 2 and 3, the translation
Table 1
Reaction steps, the kinetic types and references for reactions in the pathway
Reaction no Reaction Kinetic type Kinetic parametersa References
1 Rs + Lﬁ RL Mass action kf = 384210000; kr = 0.73 [14,17]
2 RLﬁ Ri + Li Mass action k = 0.14; E = 0.12; dT = 6.5 [14,17]
3 RL + RL = R2L2 Mass action kf = 1.383e003; kr = 0 [14,17]
4 R2L2ﬁ R2i Mass action with time delay k = 0.07; E = 0.12; dT = 6.5 [14,17]
5 R2L2 = R2–CPP Mass action kf = 0.2; kr = 3.47e004 [17,18]
6 R2–CPPﬁ R2i Mass action with time delay k = 0.35 E = 0.12; dT = 6.5; [17,18]
7 R2iﬁ Ri + Ri + Li + Li Mass action with time delay k = 0.35; E = 0.12; dT = 6.5 [17,18]
8 Ri = Rs Mass action with time delay kf = 4.84e002; kr = 0.14; E = 0.12; dT = 6.5 [17,18]
9 R2L2 + Grb2ﬁ RGrb2 Mass action k = 1e004 [15,16]
10 RGrb2ﬁ R2L2 + Grb2 Mass action k = 1e002 [15,15]
11 R2i + Grb2ﬁ RGrb2 Mass action k = 1e004 [14,15,35]
12 RGrb2ﬁ R2i + Grb2 Mass action k = 10 [14,15]
13 R2-CPP + Grb2ﬁ RGrb2 Mass action k = 1e004 [17,18]
14 RGrb2ﬁ R2-CPP + Grb2 Mass action k = 10 [17,18]
15 RGrb2 + SOSﬁ RGrb2SOS Mass action k = 50000 [14,15]
16 RGrb2SOSﬁ RGrb2SOSP Michaelis–Menten kcat = 2000; KM = 75; enzyme = MAPKP [14,15]
17 RGrb2SOSPﬁ RGrb2 + SOSP Mass action k = 50 [14,15]
18 hSOSPﬁ SOS Mass action k = 1000 [14,15]
19 Ras-GDPﬁ Ras-GTP Michaelis–Menten kcat = 1000; KM = 1000; enzyme = RGrb2SOS [17,18]
20 Ras-GTPﬁ Ras-GDP Michaelis–Menten kcat = 8; KM = 10; enzyme = GAP [17,18]
21 GAﬁGAP Mass action k = 0.75 [17,18]
22 GAPﬁ GA Michaelis–Menten kcat = 1e003; KM = 1000; enzymes: R2-CPP,
R2L2, R2i
[17,18]
23 Ras–GTP + Raf = Ras–Raf Mass action kf = 50; kr = 1e003 [17,18]
24 Ras-Rafﬁ Ras-GTP + Rafa Mass action k = 27 [17,18]
25 Rafaﬁ Raf Henri–Michaelis–Menten KM = 6000; V = 97000 [17,18]
26 MEKﬁMEKP Michaelis–Menten kcat = 50; KM = 9000; enzyme = Rafa [17,18]
27 MEKPﬁMEKPP Michaelis–Menten kcat = 50; KM = 9000; enzyme = Rafa [17,18]
28 MEKPPﬁMEKP Henri–Michaelis–Menten KM = 800000; V = 920000 [17,18]
29 MEKPﬁMEK Henri–Michaelis–Menten KM = 800000; V = 920000 [17,18]
30 ERKﬁ ERKP Michaelis–Menten kcat = 83000000; KM = 900000;
enzymes = MEKP, MEKPP
[17,18]
31 ERKPﬁ ERKPP Michaelis–Menten kcat = 83000000; KM = 900000;
enzymes = MEKP, MEKPP
[17,18]
32 ERKPPﬁ ERKP Henri–Michaelis–Menten KM = 600000; V = 400000 [17,18]
33 ERKPﬁ ERK Henri–Michaelis–Menten KM = 600000; V = 400000 [17,18]
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34 ERKPPﬁ ERKPPn Mass action k = 0.4 \
35 ERKPPnﬁ ERKPP Mass action with time delay k = 0.997; E = 0; dT = 0.01 \
36 Elk1ﬁ Elk1P phosphorylation k0f ¼ 0:01; kr = 0.05; enzyme = ERKPPn [17–19,37]
37 Elk1Pﬁ Elk1 phosphorylation kr = 0.01; k0f ¼ 0:05; enzyme = ERKPPn [17–19,37]
38 SRFﬁ SRFP phosphorylation k0f ¼ 0:1; kr = 0.01; enzyme = ERKPPn [17–19,37]
39 SRFPﬁ SRF phosphorylation kr = 0.01; k0f ¼ 0:1; enzyme = ERKPPn [17–19,37]
40 Elk1P + SRFP = SEP phosphorylation (reversible) k0f ¼ 0:5; kr = 0.3; enzyme = Elk-1, SRF [20,36–38]
41 SEP + RNApol = SEPÆRNApol Mass action kf = 1; kr = 2 [19,36,38]
42 NTPﬁ cfosRNAn Michaelis–Menten kcat = 97; KM = 200; enzyme = SEPpol [21,36,38]
43 cfosRNAnﬁ cfosRNAc Mass action k = 0.6; k = 0.8; k = 1.0 [36,38]
44 cfosRNAc + Ribosome = cfosRNAcÆribosome Mass action kf = 1; kr = 2 [21,36,38]
45 aaﬁ cfosc Michaelis–Menten kcat = 4; KM = 210; enzyme = cfosRNArib [22,36,38]
46 cfoscﬁ cfosn Mass action k = 1 \
47 cfosn + cjunn = AP1 Mass action kf = 0.43 kr = 5 [36,38]
48 AP1 + RNApol = AP1ÆRNApol Mass action kf = 1; kr = 2 [36,38]
49 NTPﬁ cjunRNAn Michaelis–Menten kcat = 97; KM = 200; enzyme = AP1pol [21,36,38]
50 cjunRNAnﬁ cjunRNAc Mass action k = 0.2; k = 0.4; k = 0.6 \
51 cjunRNAc + Ribosome = cjunRNAcÆribosome Mass action kf = 1; kr = 2 [22,36,38]
52 aaﬁ cjunc Michaelis–Mentens kcat = 4; KM = 210; enzyme = cjunRNArib [22,36,38]
53 cjuncﬁ cjunn Mass action k = 0.2 k = 0.4; k = 0.6 \
\Translocation rates based on estimation.
akf = forward rate; kr = reverse rate; KM =Michaelis–Menten constant; k = equilibrium constant; V = velocity of reaction; kcat = catalytic constant. Rate constants are in min
1 and Michaelis–Menten
and equilibrium constants are in molarities.
Mass action with delay [17]:
d½P
dt ¼ k  ðE  ð1 EÞð1 eðt=dT Þ
3ÞÞ  ½S:
Phosphorylation [37]:
d½P
dt ¼ k0f  ½S½E  kr  ½P:
Phosphorylation [37]:
d½P
dt ¼ kf  ½S1½S1þ½E1
 
 ½S2½S2þ½E2
 
 kr  ½P:
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Table 2
Initial values used for the metabolites and enzymes in the model
pathway
Metabolite Initial concentrationa Compartment References
EGF 1 · 107 M Cytoplasm [14,15,17]
Rs 10000 molecules Cytoplasm [17,18]
Ri 4000 molecules Cytoplasm [17,18]
Grb2 30000 molecules Cytoplasm [17,18]
SOS 30000 molecules Cytoplasm [14,15,17]
Ras-GDP 19800 molecules Cytoplasm [17,18]
Ras-GTP 400 molecules Cytoplasm [17,18]
GA 15000 molecules Cytoplasm [17,18]
Raf 1000 molecules Cytoplasm [17,18]
MEK 360000 molecules Cytoplasm [17,18]
ERK 750000 molecules Cytoplasm [17,18]
Elk1 10000 molecules Nucleus [19,20,35]
SRF 10000 molecules Nucleus [19,20]
NTP 6.02 · 1019 molecules Nucleus Excess
amount
(est)
Ribosome 30000 molecules Cytoplasm [22,35,36]
aa 5 · 105 molecules Cytoplasm excess
amount
(est)
RNApolymerase 20000 molecules Nucleus [21,35,36]
aUnits used for initial concentrations are in molarities, unless the
metabolite involves a translocation, in which case they have been
converted into moles. Volumes have been estimated assuming spherical
structure of the cell and entered in liters. Taking an average eukaryotic
cell to have a diameter of around 20 lm [39], the total cell volume was
calculated to be 4.2 · 106 ll, which was assumed to be 2 parts
cytoplasm and 1 part nucleus. Keeping this nuclear volume constant,
the cytoplasmic volume was altered to give Vc/Vn ratios of 1, 2, 3, and
4.
Fig. 2. Changes in c-fos protein and mRNA levels in response to
varying cytoplasmic volume (Vc) holding nuclear volume (Vn)
constant. (a) c-fos mRNA, (b) cytoplasmic c-fos protein, and (c)
nuclear c-fos protein levels (in molecules) during a 60 min time period
(solid lines, Vc/Vn = 1; dashed lines, Vc/Vn = 2; plus signs, Vc/Vn = 3;
crossed lines, Vc/Vn = 4).
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in the nuclear c-jun protein levels (Fig. 3(c)). Nuclear c-jun
protein concentration also increased with increasing Vc/Vn ra-
tio 1–3 from 3.51 · 105 to 7.62 · 105 and 1.14 · 106 molecules
per nucleus. At an atypical Vc/Vn ratio of 4, the nuclear c-jun
levels are increased about threefold, and at even higher non-
physiological ratios the program does not respond properly
(Fig. 3(c) and data not shown).
The autoregulatory loop on the c-jun promoter ensures
similar kinetic proﬁle of nuclear c-jun protein levels and nu-
clear AP-1 complex (Fig. 4). Increase in Vc/Vn also has po-
sitive eﬀect on AP-1 concentration, changing the levels from
5.44 · 104 to 9.88 · 104, 1.59 · 105, and around 2.3 · 105
molecules per nucleus as Vc/Vn ratio is increased from 1
to 2, 3, and 4 (Fig. 4). It would appear that the AP-1 com-
plex reaches a plateau irrespective of the cytoplasmic volume
change, possibly due to the positive autoregulation, however
the level of the plateau is clearly aﬀected by Vc/Vn ratios,
ultimately aﬀecting growth potential and time of cell cycle
entry of the cells.
Interestingly, in a series of experiments where the volume
of cytoplasm and the amount of DNA in the unfertilized
eggs were altered, the number of rounds of cell division dur-
ing embryogenesis of the ascidian, Halocynthia roretzi, was
found to depend on the volume of the cytoplasm and the
nucleocytoplasmic ratio, in addition to other volume-inde-
pendent factors [32,33]. It has been reported that in Dro-
sophila the nurse cells ‘‘dump’’ their cytoplasm into the
oocyte, eﬀectively increasing the oocytes cytoplasmic volume
[34]. This implies that up or downregulating a cells volumewill have signiﬁcant impact on cellular responses. We show
here that one such response aﬀected by upregulation of cyto-
plasmic volume may be the AP-1 complex, positively regu-
lating the cell cycle. Clearly, a Vc/Vn ratio of 5 and above
appears to be disrupting the cells balance, and the program
does not respond properly (data not shown), indicating that
a critical ratio has to be maintained for cell survival. This
study also indicates that changes in cytoplasmic volume
can have an eﬀect in transcription factor complexes and also
in the absolute number of transcription products in the nu-
cleus, depending on the nature of the gene being transcribed.
Fig. 4. Changes in AP-1 complex amount (in molecules per nucleus)
during a 60 min time period (solid lines, Vc/Vn = 1; dashed lines,
Vc/Vn = 2; plus signs, Vc/Vn = 3; crossed lines, Vc/Vn = 4; Vc, cyto-
plasmic volume; Vn, nuclear volume).
Fig. 3. Changes in c-jun protein and mRNA levels in response to
varying cytoplasmic volume (Vc) holding nuclear volume (Vn)
constant. (a) c-jun mRNA, (b) cytoplasmic c-jun protein, and (c)
nuclear c-jun protein levels (in molecules) during a 60 min time period
(solid lines, Vc/Vn = 1; dashed lines, Vc/Vn = 2; plus signs, Vc/Vn = 3;
crossed lines, Vc/Vn = 4).
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transcription factors can be incorporated into this model,
we can have a clearer idea of the underlying mechanism
of volume regulation. For example, the formation of AP-1
complex is in fact more complex than is presented in this
model; both c-fos and c-jun protein synthesis and regulation
are dependent on pathways parallel to, but diﬀerent than,
the ERK pathway. These pathways have not been included
in this model for the sake of simplicity, but shall in the fu-
ture be a topic of more comprehensive study.Acknowledgments: We acknowledge Prof. Dr. Yorgo Istefanopoulos
and the Institute of Biomedical Engineering at Bogazici University
for their support of this project.References
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